Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?

Jianzhi Ren; Aiguo Sha; Dongmei Han; Ping Li; Jie Geng; Chaihui Ma

doi:10.1016/j.fertnstert.2014.03.030

Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?

Jianzhi Ren, Aiguo Sha, Dongmei Han, Ping Li, Jie Geng, Chaihui Ma

In: Fertility and Sterility · 2014 · vol. 102(1) , pp. 75–81 · doi:10.1016/j.fertnstert.2014.03.030 · PMID:24746740 · W2091297961

article OA: bronze CC0 ⤵ 5 in-corpus citations

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated whether prolonged pituitary down-regulation with a GnRH agonist enhances live-birth rates in IVF treatments.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (44)

Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy via openalex
Effect of endometriosis on in vitro fertilization via openalex
Effect of GnRH analogues on apoptosis and release of interleukin-1 and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis via openalex
Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis via openalex
Endometriosis and infertility: pathophysiology and management via openalex
Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study* via openalex
Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis via openalex
Ovarian stimulation for <i>in vitro</i> fertilization in patients with endometriosis via openalex
Tumor Necrosis Factor-α-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably through Nuclear Factor-κB Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression via openalex
doi:10.1016/s0015-0282(98)00123-x via openalex
doi:10.1016/j.ejogrb.2011.06.030 via openalex
doi:10.1186/1477-7827-1-125 via openalex
doi:10.1198/016214508000000733 via openalex
doi:10.1093/humupd/dmt030 via openalex
doi:10.1159/000292997 via openalex
doi:10.1016/j.fertnstert.2007.01.013 via openalex
doi:10.1093/humrep/del173 via openalex
doi:10.1093/humrep/del215 via openalex
doi:10.1093/humrep/16.3.492 via openalex
doi:10.1186/1477-7827-8-30 via openalex
doi:10.1093/humrep/17.8.2016 via openalex
doi:10.1093/humrep/15.5.1003 via openalex
doi:10.1186/1477-7827-10-26 via openalex
doi:10.1016/s0015-0282(16)60435-1 via openalex
doi:10.1093/molehr/5.3.234 via openalex
doi:10.1093/humrep/deh183 via openalex
doi:10.1093/oxfordjournals.humrep.a136126 via openalex
doi:10.1016/j.fertnstert.2006.05.064 via openalex
doi:10.4103/0974-1208.97785 via openalex
doi:10.1093/humrep/deh235 via openalex
doi:10.1016/s1472-6483(10)60781-x via openalex
doi:10.3109/09513599209015549 via openalex
doi:10.1016/s0301-2115(98)00125-0 via openalex
doi:10.1093/humrep/10.suppl_2.60 via openalex
doi:10.1016/0140-6736(91)90427-q via openalex
doi:10.1016/j.fertnstert.2007.07.1316 via openalex
doi:10.1159/000214844 via openalex
doi:10.1007/s10815-006-9051-3 via openalex
doi:10.1016/j.fertnstert.2008.11.027 via openalex
doi:10.1186/1477-7827-6-37 via openalex
doi:10.1016/s1472-6483(10)61729-4 via openalex
doi:10.1016/s1472-6483(10)60426-9 via openalex
doi:10.1007/bf01203956 via openalex
doi:10.1093/humrep/13.7.1788 via openalex

Cited by (5)

Source provenance

openalex: last seen: 2026-05-11T06:01:13.017405+00:00

License: CC0 · commercial use OK

[1] Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy via openalex

[2] Effect of endometriosis on in vitro fertilization via openalex

[3] Effect of GnRH analogues on apoptosis and release of interleukin-1 and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis via openalex

[4] Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis via openalex

[5] Endometriosis and infertility: pathophysiology and management via openalex

[6] Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study* via openalex

[7] Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis via openalex

[8] Ovarian stimulation for <i>in vitro</i> fertilization in patients with endometriosis via openalex

[9] Tumor Necrosis Factor-α-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably through Nuclear Factor-κB Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression via openalex

[10] doi:10.1016/s0015-0282(98)00123-x via openalex

[11] doi:10.1016/j.ejogrb.2011.06.030 via openalex

[12] doi:10.1186/1477-7827-1-125 via openalex

[13] doi:10.1198/016214508000000733 via openalex

[14] doi:10.1093/humupd/dmt030 via openalex

[15] doi:10.1159/000292997 via openalex

[16] doi:10.1016/j.fertnstert.2007.01.013 via openalex

[17] doi:10.1093/humrep/del173 via openalex

[18] doi:10.1093/humrep/del215 via openalex

[19] doi:10.1093/humrep/16.3.492 via openalex

[20] doi:10.1186/1477-7827-8-30 via openalex

[21] doi:10.1093/humrep/17.8.2016 via openalex

[22] doi:10.1093/humrep/15.5.1003 via openalex

[23] doi:10.1186/1477-7827-10-26 via openalex

[24] doi:10.1016/s0015-0282(16)60435-1 via openalex

[25] doi:10.1093/molehr/5.3.234 via openalex

[26] doi:10.1093/humrep/deh183 via openalex

[27] doi:10.1093/oxfordjournals.humrep.a136126 via openalex

[28] doi:10.1016/j.fertnstert.2006.05.064 via openalex

[29] doi:10.4103/0974-1208.97785 via openalex

[30] doi:10.1093/humrep/deh235 via openalex

[31] doi:10.1016/s1472-6483(10)60781-x via openalex

[32] doi:10.3109/09513599209015549 via openalex

[33] doi:10.1016/s0301-2115(98)00125-0 via openalex

[34] doi:10.1093/humrep/10.suppl_2.60 via openalex

[35] doi:10.1016/0140-6736(91)90427-q via openalex

[36] doi:10.1016/j.fertnstert.2007.07.1316 via openalex

[37] doi:10.1159/000214844 via openalex

[38] doi:10.1007/s10815-006-9051-3 via openalex

[39] doi:10.1016/j.fertnstert.2008.11.027 via openalex

[40] doi:10.1186/1477-7827-6-37 via openalex

[41] doi:10.1016/s1472-6483(10)61729-4 via openalex

[42] doi:10.1016/s1472-6483(10)60426-9 via openalex

[43] doi:10.1007/bf01203956 via openalex

[44] doi:10.1093/humrep/13.7.1788 via openalex